Publisher
Springer Berlin Heidelberg
Reference61 articles.
1. Altamura AC, Curry SH, Montgomery S, Wiles DH (1985) Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients. Psychopharmacology 87: 30–33
2. Axelsson R, Märtensson E (1978) Relationship between serum concentrations of thioridazine and its main nonconjugated metabolites and clinical response in thioridazine-treated patients. Curr Ther Res 24: 232–242
3. Bianchetti G, Zarifian E, Poirier-Littre MF, Morselli PL, Deniker P (1980) Influence of route of administration on haloperidol plasma levels in psychotic patients. Int J Clin Pharmacol Ther Toxicol 18: 324–327
4. Bolvig Hansen L, Larsen NE (1977) Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment. Psychopharmacology 53: 127–130
5. Bolvig Hansen L, Larsen NE (1985) Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice. Psychopharmacology 87: 16–19
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Schizophrene Psychosen;Psychiatrie, Psychosomatik, Psychotherapie;2011
2. Schizophrene Psychosen;Psychiatrie und Psychotherapie;2008
3. Stellenwert und Grenzen klassischer Neuroleptika in der Akuttherapie schizophrener Erkrankungen;Therapie mit klassischen und neuen Neuroleptika;1998
4. Klinik;Neuro-Psychopharmaka Ein Therapie-Handbuch;1992
5. Typical Neuroleptics in the Treatment of Positive and Negative Symptoms;Negative Versus Positive Schizophrenia;1991